Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Sutton

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Immunology|March 24, 2021
A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosisHaipei Liu, Sohinee Sarkar, Kristy Azzopardi, et al.
Veterinary Immunology and Immunopathology|April 16, 2011
Mucosal vaccination: lung versus noseAna Vujanic, Philip Sutton, Kenneth J Snibson, et al.
Helicobacter|January 27, 2009
Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infectionAlison L Every, Yok-Teng Chionh, Caroline D Skene, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2003
Protective immunity against Helicobacter is characterized by a unique transcriptional signatureAnne Mueller, Jani O'Rourke, Pauline Chu, et al.
Infection and Immunity|April 22, 2009
M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogensYok-Teng Chionh, Janet L K Wee, Alison L Every, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2Sophie Lees, Suzanne B Golub, Karena Last, et al.
BMJ Open Respiratory Research|January 20, 2025
Protease-activated receptor 1 in the pathogenesis of cystic fibrosisSohinee Sarkar, Jia-Xi Han, Kristy Azzopardi, et al.
Vaccine|December 22, 2010
Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigenAlison L Every, Andrew Stent, Margaret B Moloney, et al.
Vaccine|October 23, 2012
Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccinesAndrew Stent, Alison L Every, Garrett Z Ng, et al.
Anticancer Research|September 21, 2012
PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese populationNatalia Castaño-Rodríguez, Nadeem O Kaakoush, Khean-Lee Goh, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Immunology|March 24, 2021
A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosisHaipei Liu, Sohinee Sarkar, Kristy Azzopardi, et al.
Veterinary Immunology and Immunopathology|April 16, 2011
Mucosal vaccination: lung versus noseAna Vujanic, Philip Sutton, Kenneth J Snibson, et al.
Helicobacter|January 27, 2009
Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infectionAlison L Every, Yok-Teng Chionh, Caroline D Skene, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2003
Protective immunity against Helicobacter is characterized by a unique transcriptional signatureAnne Mueller, Jani O'Rourke, Pauline Chu, et al.
Infection and Immunity|April 22, 2009
M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogensYok-Teng Chionh, Janet L K Wee, Alison L Every, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2Sophie Lees, Suzanne B Golub, Karena Last, et al.
BMJ Open Respiratory Research|January 20, 2025
Protease-activated receptor 1 in the pathogenesis of cystic fibrosisSohinee Sarkar, Jia-Xi Han, Kristy Azzopardi, et al.
Vaccine|December 22, 2010
Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigenAlison L Every, Andrew Stent, Margaret B Moloney, et al.
Vaccine|October 23, 2012
Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccinesAndrew Stent, Alison L Every, Garrett Z Ng, et al.
Anticancer Research|September 21, 2012
PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese populationNatalia Castaño-Rodríguez, Nadeem O Kaakoush, Khean-Lee Goh, et al.
Pageof 7